TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's Disease

NCT02522169 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Crohns Disease

Interventions

DRUG: Infliximab

Sponsor

Klinikum Westbrandenburg GmbH